1. Hypoxia-inducible factor-1 mediates pancreatic β-cell dysfunction by intermittent hypoxia
- Author
-
Benjamin Wang, Nanduri R. Prabhakar, Shakil A. Khan, Gregg L. Semenza, Jayasri Nanduri, Xue Feng Shi, and Ning Wang
- Subjects
Male ,Transcriptional Activation ,0301 basic medicine ,Digoxin ,Heterozygote ,medicine.medical_specialty ,Physiology ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Insulin resistance ,Downregulation and upregulation ,Insulin-Secreting Cells ,Internal medicine ,medicine ,Animals ,Insulin ,Secretion ,RNA, Small Interfering ,Hypoxia ,Mice, Knockout ,chemistry.chemical_classification ,Sleep Apnea, Obstructive ,Reactive oxygen species ,NADPH oxidase ,biology ,NOX4 ,Intermittent hypoxia ,Hydrogen Peroxide ,Cell Biology ,Hypoxia-Inducible Factor 1, alpha Subunit ,medicine.disease ,Mice, Inbred C57BL ,Oxygen ,Disease Models, Animal ,Glucose ,030104 developmental biology ,Endocrinology ,Hypoxia-inducible factors ,chemistry ,NADPH Oxidase 4 ,biology.protein ,Insulin Resistance ,030217 neurology & neurosurgery ,Research Article - Abstract
The role of hypoxia-inducible factor (HIF)-1 in pancreatic β-cell response to intermittent hypoxia (IH) was examined. Studies were performed on adult wild-type (WT), HIF-1α heterozygous (HET), β-cell-specific HIF-1−/− mice and mouse insulinoma (MIN6) cells exposed to IH patterned after blood O2 profiles during obstructive sleep apnea. WT mice treated with IH showed insulin resistance, and pancreatic β-cell dysfunction manifested as augmented basal insulin secretion, and impaired glucose-stimulated insulin secretion and these effects were absent in HIF-1α HET mice. IH increased HIF-1α expression and elevated reactive oxygen species (ROS) levels in β-cells of WT mice. The elevated ROS levels were due to transcriptional upregulation of NADPH oxidase (NOX)-4 mRNA, protein and enzymatic activity, and these responses were absent in HIF-1α HET mice as well as in β-HIF-1−/− mice. IH-evoked β-cell responses were absent in adult WT mice treated with digoxin, an inhibitor of HIF-1α. MIN6 cells treated with in vitro IH showed enhanced basal insulin release and elevated HIF-1α protein expression, and these effects were abolished with genetic silencing of HIF-1α. IH increased NOX4 mRNA, protein, and enzyme activity in MIN6 cells and disruption of NOX4 function by siRNA or scavenging H2O2 with polyethylene glycol catalase blocked IH-evoked enhanced basal insulin secretion. These results demonstrate that HIF-1-mediated transcriptional activation of NOX4 and the ensuing increase in H2O2 contribute to IH-induced pancreatic β-cell dysfunction.
- Published
- 2020
- Full Text
- View/download PDF